Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.97 |
| ▸ | NPC1 | O15118 | 1/20 | 0.97 |
| ▸ | MAPT | P10636 | 1/20 | 0.97 |
| ▸ | RAB9A | P51151 | 1/20 | 0.97 |
| ▸ | LMNA | P02545 | 4/20 | 0.90 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.90 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.90 |
| ▸ | TSHR | P16473 | 4/20 | 0.90 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.90 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.90 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.90 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.75 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.75 |
| ▸ | HTR1A | P08908 | 1/20 | 0.75 |
| ▸ | GAA | P10253 | 1/20 | 0.75 |
| ▸ | DRD3 | P35462 | 1/20 | 0.75 |
| ▸ | SCN1A | P35498 | 1/20 | 0.75 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.75 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.75 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1265146 | 0.98 | ALDH1A1 (1.00) | ALDH1A1NPC1MAPTRAB9ALMNA | |
| SCHEMBL769503 | 0.98 | ALDH1A1 (1.00) | ALDH1A1NPC1MAPTRAB9ALMNA | |
| SCHEMBL10663602 | 0.98 | ALDH1A1 (1.00) | ALDH1A1NPC1MAPTRAB9ALMNA | |
| SCHEMBL204048 | 0.98 | ALDH1A1 (1.00) | ALDH1A1NPC1MAPTRAB9ALMNA | |
| SCHEMBL1265838 | 0.98 | ALDH1A1 (1.00) | ALDH1A1NPC1MAPTRAB9ALMNA | |
| SCHEMBL3320139 | 0.98 | ALDH1A1 (1.00) | ALDH1A1NPC1MAPTRAB9ALMNA | |
| SCHEMBL28281238 | 0.98 | ALDH1A1 (1.00) | ALDH1A1NPC1MAPTRAB9ALMNA | |
| SCHEMBL9068530 | 0.98 | ALDH1A1 (1.00) | ALDH1A1NPC1MAPTRAB9ALMNA | |
| Ammonia Solution, Strong SCHEMBL11630445 | 0.97 | ALDH1A1 (0.97) | ALDH1A1NPC1MAPTRAB9ALMNA | |
| Nitrogen SCHEMBL27803563 | 0.97 | ALDH1A1 (0.91) | ALDH1A1NPC1MAPTRAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117625272-A | Gear oil composition | 中国石油化工股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117625250-A | Scale inhibition composition and application thereof | 中国石油化工股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117625288-A | Lubricating oil composition special for unmanned aerial vehicle | 中国石油化工股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116063589-A | Soot ashless dispersant, and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-109415553-B | Plasticized thermoset resins and related cured resins, curing methods, and articles comprising cured resins | 马萨诸塞大学 | 2022-08-05 | — | — | CN | claimed |
| EP-3481899-A1 | PLASTICIZED THERMOSET RESIN, AND ASSOCIATED CURED RESIN, METHOD OF CURING, AND ARTICLE COMPRISING CURED RESIN | The University of Massachusetts (US) | 2019-05-15 | — | — | EP | claimed |
| CN-109415553-A | The thermosetting resin of plasticising and related solidified resin, curing method and the product comprising solidified resin | 马萨诸塞大学 | 2019-03-01 | — | — | CN | claimed |
| WO-2018008003-A1 | PLASTICIZED THERMOSET RESIN, AND ASSOCIATED CURED RESIN, METHOD OF CURING, AND ARTICLE COMPRISING CURED RESIN | THE UNIVERSITY OF MASSACHUSETTS (US) | 2018-01-11 | — | — | WO | claimed |
| CN-106751559-A | A kind of ultraviolet aging resistance PBAT thin-film materials and preparation method thereof | 华南理工大学 | 2017-05-31 | — | — | CN | claimed |
| US-8318659-B2 | Peptide-based organic sunscreens | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-27 | — | — | US | claimed |
| WO-2008073368-A1 | PEPTIDE-BASED HAIR PROTECTANTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-06-19 | — | — | WO | claimed |
| EP-1928397-A1 | METHOD FOR ENHANCING EFFECTS OF COLORANTS AND CONDITIONERS | E.I.Du pont de nemours and company (US) | 2008-06-11 | — | — | EP | claimed |
| WO-2007059076-A2 | PEPTIDE-BASED ORGANIC SUNSCREENS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-24 | — | — | WO | claimed |
| US-20070110686-A1 | Peptide-based organic sunscreens | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-17 | — | — | US | claimed |
| WO-2007038733-A1 | METHOD FOR ENHANCING EFFECTS OF COLORANTS AND CONDITIONERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-05 | — | — | WO | claimed |
| US-20070067924-A1 | Method for enhancing effects of colorants and conditioners | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-03-29 | — | — | US | claimed |
| US-20060134095-A1 | Antioxidative composition and composition for external use | VITAMIN C60 BIORESEARCH CORPORATION (JP) | 2006-06-22 | — | — | US | claimed |
| CN-1753968-A | Antioxidant composition and external composition | MITSUBISHI CORP (JP) | 2006-03-29 | — | — | CN | claimed |
| EP-1595936-A1 | ANTIOXIDATIVE COMPOSITION AND COMPOSITION FOR EXTERNAL USE | MITSUBISHI CORPORATION (JP) | 2005-11-16 | — | — | EP | claimed |
| US-4726942-A | SUNSCREEN AGENTS | L'OREAL (FR) | 1988-02-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060134095-A1 | Antioxidative composition and composition for external use | GPX4, GPX1, SOD1 | ALDH1A1 1109/4885NPC1 1691/4885MAPT 3027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.